By limiting our active portfolio to 15 companies we have the bandwidth to provide more than just capital.
Our years of experience help entrepreneurs grow smartly, mitigate risk and expand impact.
We invest the majority of our fund in Europe and the rest in the US. We bridge the continents for our portfolio companies, facilitating partnerships and building international networks to help everyone succeed.
GEOGRAPHY
Europe & United States
SECTORS
Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics
STAGE
From seed to public offerings
INVESTMENT CRITERIA
Potential for a strong exit within 4 to 6 years
FUNDS
€176M total; investments
of €7M to €10M
SYNDICATION
Will lead or co-lead an investment syndicate